CD133⁺ cells isolated from various sources and their role in future clinical perspectives

Bibliography

• Corbeil D, Roper K, Fargeas CA, Prominin: a story of cholesterol, plasma membrane protrusions and human pathology. Traffic 2001;2:82-91
   PubMed Web of Science ®Google Scholar
• Miraglia S, Godfrey W, Yin AH, A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood 1997;90:5013-21
   PubMed Web of Science ®Google Scholar
• Yin AH, Miraglia S, Zanjani ED, AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 1997;90:5002-12
   PubMed Web of Science ®Google Scholar
• Shmelkov SV, Jun L, St Clair R, Alternative promoters regulate transcription of the gene that encodes stem cell surface protein AC133. Blood 2004;103:2055-61
   PubMed Web of Science ®Google Scholar
• Corbeil D, Roper K, Hellwig A, The human AC133 hematopoietic stem cell antigen is also expressed in epithelial cells and targeted to plasma membrane protrusions. J Biol Chem 2000;275:5512-20
   PubMed Web of Science ®Google Scholar
• Buhring HJ, Seiffert M, Marxer A, AC133 antigen expression is not restricted to acute myeloid leukemia blasts but is also found on acute lymphoid leukemia blasts and on a subset of CD34+ B-cell precursors. Blood 1999;94:832-3
   PubMed Web of Science ®Google Scholar
• Kratz-Albers K, Zuhlsdorp M, Leo R, Expression of a AC133, a novel stem cell marker, on human leukemic blasts lacking CD34-antigen and on a human CD34+ leukemic line:MUTZ-2. Blood 1998;92:4485-7
   PubMed Web of Science ®Google Scholar
• Torrente Y, Belicchi M, Sampaolesi M, Human circulating AC133(+) stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle. J Clin Invest 2004;114:182-95
   PubMed Web of Science ®Google Scholar
• Uchida N, Buck DW, He D, Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci USA 2000;97:14720-5
   PubMed Web of Science ®Google Scholar
• Singh SK, Hawkins C, Clarke ID, Identification of human brain tumour initiating cells. Nature 2004;432:396-401
   PubMed Web of Science ®Google Scholar
• O'Brien CA, Pollett A, Gallinger S, A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007;445:106-10
   PubMed Web of Science ®Google Scholar
• Uchida S, Yokoo S, Yanagi Y, Sphere formation and expression of neural proteins by human corneal stromal cells in vitro. Invest Ophthalmol Vis Sci 2005;46:1620-5
   PubMed Web of Science ®Google Scholar
• Shmelkov SV, Butler JM, Hooper AT, CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors. J Clin Invest 2008;118:2111-20
   PubMed Web of Science ®Google Scholar
• Ricci-Vitiani L, Lombardi DG, Pilozzi E, Identification and expansion of human colon-cancer-initiating cells. Nature 2007;445:111-15
   PubMed Web of Science ®Google Scholar
• LaBarge MA, Petersen OW, Bissell MJ. Of microenvironments and mammary stem cells. Stem Cell Rev 2007;3:137-46
   PubMed Web of Science ®Google Scholar
• Sneddon JB, Werb Z. Location, location, location: the cancer stem cell niche. Cell Stem Cell 2007;1:607-11
   PubMed Web of Science ®Google Scholar
• Yen TH, Wright NA. The gastrointestinal tract stem cell niche. Stem Cell Rev 2006;2:203-12
   PubMed Web of Science ®Google Scholar
• Florek M, Haase M, Marzesco AM, Prominin-1/CD133, a neural and hematopoietic stem cell marker, is expressed in adult human differentiated cells and certain types of kidney cancer. Cell Tissue Res 2005;319:15-26
   PubMed Web of Science ®Google Scholar
• Ray PN, Belfall B, Duff C, Cloning of the breakpoint of an X;21 translocation associated with Duchenne muscular dystrophy. Nature 1985;318:672-5
   PubMed Web of Science ®Google Scholar
• Matsumura K, Ohlendieck K, Ionasescu VV, The role of the dystrophin-glycoprotein complex in the molecular pathogenesis of muscular dystrophies. Neuromuscul Disord 1993;3:533-5
   PubMedGoogle Scholar
• Hoffman EP, Brown RH Jr, Kunkel LM. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 1987;51:919-28
   PubMed Web of Science ®Google Scholar
• Ribatti D. The involvement of endothelial progenitor cells in tumor angiogenesis. J Cell Mol Med 2004;8:294-300
   PubMed Web of Science ®Google Scholar
• Gavina M, Belicchi M, Rossi B, VCAM-1 expression on dystrophic muscle vessels has a critical role in the recruitment of human blood-derived CD133+ stem cells after intra-arterial transplantation. Blood 2006;108:2857-66
   PubMed Web of Science ®Google Scholar
• Yamamoto K, Kondo T, Suzuki S, Molecular evaluation of endothelial progenitor cells in patients with ischemic limbs: therapeutic effect by stem cell transplantation. Arterioscler Thromb Vasc Biol 2004;24:e192-6
   PubMed Web of Science ®Google Scholar
• Limsuwan A, Pienvichit P, Limpijankit T, Transcoronary bone marrow-derived progenitor cells in a child with myocardial infarction: first pediatric experience. Clin Cardiol 2010;33:E7-12
   PubMed Web of Science ®Google Scholar
• Torrente Y, Belicchi M, Marchesi C, Autologous transplantation of muscle-derived CD133+ stem cells in Duchenne muscle patients. Cell Transplant 2010;16:563-77
   Google Scholar
• Bhatia R, Munthe HA, Williams AD, Chronic myelogenous leukemia primitive hematopoietic progenitors demonstrate increased sensitivity to growth factor-induced proliferation and maturation. Exp Hematol 2000;28:1401-12
   PubMed Web of Science ®Google Scholar
• Lang P, Bader P, Schumm M, Transplantation of a combination of CD133+ and CD34+ selected progenitor cells from alternative donors. Br J Haematol 2004;124:72-9
   PubMed Web of Science ®Google Scholar
• Stamm C, Westphal B, Kleine HD, Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 2003;361:45-6
   PubMed Web of Science ®Google Scholar
• Benchaouir R, Meregalli M, Farini A, Restoration of human dystrophin following transplantation of exon-skipping-engineered DMD patient stem cells into dystrophic mice. Cell Stem Cell 2007;1:646-57
   PubMed Web of Science ®Google Scholar
• Flores-Ramirez R, Uribe-Longoria A, Rangel-Fuentes MM, Intracoronary infusion of CD133+ endothelial progenitor cells improves heart function and quality of life in patients with chronic post-infarct heart insufficiency. Cardiovasc Revasc Med;2010:11:72-8
   PubMedGoogle Scholar
• Navarro-Sobrino M, Rosell A, Hernandez-Guillamon M, Mobilization, endothelial differentiation and functional capacity of endothelial progenitor cells after ischemic stroke. Microvasc Res 2010 [Epub ahead of print]
   Google Scholar
• Smith S, Neaves W, Teitelbaum S. Adult stem cell treatments for diseases? Science 2006;313:439
   PubMed Web of Science ®Google Scholar
• Sampaolesi M, Blot S, D'Antona G, Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature 2006;444:574-9
   PubMed Web of Science ®Google Scholar
• Mavilio F, Pellegrini G, Ferrari S, Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells. Nat Med 2006;12:1397-402
   PubMed Web of Science ®Google Scholar
• Graf T, Stadtfeld M. Heterogeneity of embryonic and adult stem cells. Cell Stem Cell 2008;3:480-3
   PubMed Web of Science ®Google Scholar
• Negroni E, Riederer I, Chaouch S, In vivo myogenic potential of human CD133+ muscle-derived stem cells: a quantitative study. Mol Ther 2009;17:1771-8
   PubMed Web of Science ®Google Scholar
• Cossu G, Bianco P. Mesoangioblasts – vascular progenitors for extravascular mesodermal tissues. Curr Opin Genet Dev 2003;13:537-42
   PubMed Web of Science ®Google Scholar
• Grounds MD, McGeachie JK. A model of myogenesis in vivo, derived from detailed autoradiographic studies of regenerating skeletal muscle, challenges the concept of quantal mitosis. Cell Tissue Res 1987;250:563-9
   PubMed Web of Science ®Google Scholar
• Price FD, Kuroda K, Rudnicki MA. Stem cell based therapies to treat muscular dystrophy. Biochim Biophys Acta 2007;1772:272-83
   PubMed Web of Science ®Google Scholar
• Peault B, Rudnicki M, Torrente Y, Stem and progenitor cells in skeletal muscle development, maintenance, and therapy. Mol Ther 2007;15:867-77
   PubMed Web of Science ®Google Scholar